A 4-arm Clinical Trial of Fuse®, EndoCuff™, EndoRings™ and Standard Colonoscopy

Completed · Not applicable

Conditions studied: Colorectal Neoplasms

In brief

Adenoma detection rate (ADR) is a validated marker for reducing the risk of interval colorectal cancer after a screening colonoscopy. Recent studies suggest that novel devices attached to the colonoscope tip may improve the ADR of doctors performing a screening procedure

Key facts

Study ID

NCT02345889

Run by

Indiana University

People needed

1262

Starts

2015-02-01

Expected to finish

2017-12-01

Last updated by the study team

2019-03-12

Who can join

Age: 50 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Screening or Surveillance Colonoscopy

You may not qualify if…

• Personal history of Colorectal cancer or Inflammatory bowel disease
• Surgical resection of the colon or known colonic stricture
• Personal or family history of Polyposis syndromes or Lynch syndrome
• Referral for incomplete colonoscopy or known therapeutic polyp clearance
• Severe diverticular disease
• Referral for a positive hemoccult test in the past 6 months
• Known coagulopathy
• Inability to provide informed consent

Where it is running

• Indiana University Hospital — Indianapolis, Indiana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.